28M 5MG MIN 0.5MG DUT - CROWN FILLING IN 5/9/2026
A 28-year-old male reported significant hair regrowth using 5mg minoxidil and 0.5mg dutasteride over five months, with occasional ketoconazole use. Users discussed side effects like stuffy nose and low libido, and shared experiences with different hair loss treatments.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity Happy with progress! 1+ yr regrowth- DHT blockers and Minoxidil
The user experienced significant hair regrowth using dutasteride, oral minoxidil, and ketoconazole shampoo, with no side effects except denser facial hair. They increased their dosages to 1mg dutasteride and 5mg oral minoxidil for better results.
community Almost 1 year on dutasteride and oral minoxidil
The user has been using 0.5mg dutasteride and 5mg oral minoxidil daily, along with 2% ketoconazole shampoo, for almost a year with no side effects. They report positive results in hair regrowth.
community M30, month 1 of dutasteride and minoxidil
A 30-year-old male is using a regimen of dutasteride, minoxidil, ketoconazole shampoo, tretinoin cream, and microneedling for hair regrowth. He reports no side effects and has noticed visual improvement after one month.
community 22m Dutasteride + Min + Ket 1 year
A 22-year-old male shared his one-year progress using dutasteride, minoxidil, and ketoconazole shampoo for hair regrowth, showing significant improvement. Users discussed the effectiveness of these treatments, with some confusion about ketamine, and shared their own experiences and questions about dosages and side effects.
community Put together a list of hair treatment protocols from the community posts
Finasteride and minoxidil, often with ketoconazole, are key for long-term hair stabilization and regrowth. Oral minoxidil and dutasteride offer significant regrowth but have more side effects, while microneedling, ketoconazole shampoo, and RU58841 are used to enhance results.
community 1 month of 0.5 Dut + 2.5 Oral Min + Ketoconazole Shampoo
The user experienced significant hair regrowth in temples, eyebrows, eyelashes, and beard after one month of using 0.5 mg Dutasteride, 2.5 mg Oral Minoxidil, and Ketoconazole Shampoo, with no side effects. They are still experiencing scalp shedding but expect further progress.
Related Research
6 / 6 resultsresearch Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA
This pilot study found that a novel regimen including NuH Hair led to significant hair growth in male patients with androgenic alopecia, regardless of atopy status, with quicker results when additional treatment components were used.
research Addressing Androgenetic Alopecia-A Complex Disorder-with a Multilateral Treatment Strategy
This review discusses recent advancements in understanding the pathophysiology of androgenetic alopecia and highlights the potential for multilateral topical therapies to improve treatment efficacy with fewer side effects; it reports no new clinical results.
research Male pattern baldness: current treatments, future prospects
This review addresses the limited efficacy of current treatments for male pattern baldness and explains that emerging genetic insights could lead to more effective future therapies.
research Medical treatments for male and female pattern hair loss
This review discusses the various treatment options for male and female pattern hair loss and provides no new clinical results; the authors outline the most effective strategies based on existing evidence.
research Treat androgenetic alopecia with antiandrogens, as well as other pharmacological and non-pharmacological interventions
This review discusses current treatment options for androgenetic alopecia, noting that most lack robust evidence for efficacy and safety, highlighting the need for more comprehensive studies.
research Female pattern alopecia: current perspectives
This review discusses the current therapeutic options for female pattern hair loss and emphasizes the need for managing patient expectations of permanent regrowth, reporting no new clinical results.